A detailed history of Black Rock Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Black Rock Inc. holds 11,376,096 shares of EXAS stock, worth $471 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,376,096
Previous 11,053,013 2.92%
Holding current value
$471 Million
Previous $818 Million 3.92%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$56.27 - $73.77 $18.2 Million - $23.8 Million
323,083 Added 2.92%
11,376,096 $786 Million
Q4 2023

Feb 13, 2024

SELL
$59.06 - $75.72 $30.9 Million - $39.6 Million
-522,545 Reduced 4.51%
11,053,013 $818 Million
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $26.6 Million - $39.9 Million
402,846 Added 3.61%
11,575,558 $790 Million
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $32.5 Million - $49.3 Million
519,159 Added 4.87%
11,172,712 $1.05 Billion
Q1 2023

May 12, 2023

SELL
$47.19 - $70.77 $33.1 Million - $49.6 Million
-701,005 Reduced 6.17%
10,653,553 $722 Million
Q4 2022

Feb 13, 2023

BUY
$30.35 - $53.15 $27.8 Million - $48.7 Million
916,620 Added 8.78%
11,354,558 $562 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $13.4 Million - $20.7 Million
418,605 Added 4.18%
10,437,938 $339 Million
Q2 2022

Aug 12, 2022

BUY
$35.61 - $76.23 $8.18 Million - $17.5 Million
229,781 Added 2.35%
10,019,333 $395 Million
Q1 2022

May 12, 2022

BUY
$57.56 - $82.54 $16.8 Million - $24.1 Million
292,540 Added 3.08%
9,789,552 $684 Million
Q4 2021

Feb 10, 2022

BUY
$72.5 - $100.68 $59.8 Million - $83 Million
824,511 Added 9.51%
9,497,012 $739 Million
Q3 2021

Nov 09, 2021

SELL
$90.24 - $124.05 $24.3 Million - $33.4 Million
-268,898 Reduced 3.01%
8,672,501 $828 Million
Q2 2021

Aug 11, 2021

BUY
$93.66 - $139.27 $837 Million - $1.25 Billion
8,941,399 New
8,941,399 $1.11 Billion

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.32B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.